Twist Bioscience
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $88,713 | $84,710 | $81,464 | $75,302 |
Gross Profit | 42,840 | 38,233 | 35,271 | 30,882 |
EBITDA | -25,093 | -28,067 | -77,080 | -36,847 |
EBIT | -31,473 | -34,723 | -85,380 | -45,147 |
Net Income | -31,594 | -34,655 | -85,571 | -45,492 |
Net Change In Cash | 88,713 | 84,710 | 81,464 | 75,302 |
Free Cash Flow | -23,696 | -17,322 | -7,343 | -20,026 |
Cash | 221,403 | 226,316 | 239,142 | 243,348 |
Basic Shares | 59,162 | 58,016 | 58,145 | 57,779 |
Annual Financials
| Values in thousands | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 |
|---|---|---|---|---|
Revenue | $312,974 | $245,109 | $203,565 | $132,333 |
Gross Profit | 133,349 | 89,729 | 84,235 | 51,713 |
EBITDA | -176,705 | -174,151 | -247,046 | -143,911 |
EBIT | -208,137 | -203,461 | -249,021 | -155,904 |
Net Income | -208,726 | -204,618 | -217,863 | -152,098 |
Net Change In Cash | 312,974 | 245,109 | 203,565 | 132,333 |
Cost of Revenue | -86,781 | 373,093 | ||
Free Cash Flow | -69,170 | -170,253 | -226,242 | -139,305 |
Cash | 226,316 | 286,470 | 378,687 | 465,829 |
Basic Shares | 58,016 | 56,885 | 53,885 | 48,251 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | -$0.53 |
2024-09-30 | -$0.59 |
2024-06-30 | -$1.47 |
2024-03-31 | -$0.79 |
